NAVB
T. Rowe Price Associates’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-70,000
| Closed | -$29K | – | 2630 |
|
|
2017
Q3 | $29K | Hold |
70,000
| – | – | ﹤0.01% | 2544 |
|
|
2017
Q2 | $36K | Hold |
70,000
| – | – | ﹤0.01% | 2542 |
|
|
2017
Q1 | $40K | Hold |
70,000
| – | – | ﹤0.01% | 2552 |
|
|
2016
Q4 | $44K | Hold |
70,000
| – | – | ﹤0.01% | 2527 |
|
|
2016
Q3 | $64K | Hold |
70,000
| – | – | ﹤0.01% | 2487 |
|
|
2016
Q2 | $37K | Sell |
70,000
-400
| -0.6% | -$211 | ﹤0.01% | 2492 |
|
|
2016
Q1 | $66K | Hold |
70,400
| – | – | ﹤0.01% | 2456 |
|
|
2015
Q4 | $94K | Buy |
70,400
+400
| +0.6% | +$534 | ﹤0.01% | 2432 |
|
|
2015
Q3 | $160K | Hold |
70,000
| – | – | ﹤0.01% | 2333 |
|
|
2015
Q2 | $113K | Hold |
70,000
| – | – | ﹤0.01% | 2443 |
|
|
2015
Q1 | $111K | Buy |
70,000
+30,000
| +75% | +$47.6K | ﹤0.01% | 2459 |
|
|
2014
Q4 | $76K | Hold |
40,000
| – | – | ﹤0.01% | 2495 |
|
|
2014
Q3 | $53K | Hold |
40,000
| – | – | ﹤0.01% | 2517 |
|
|
2014
Q2 | $59K | Hold |
40,000
| – | – | ﹤0.01% | 2504 |
|
|
2014
Q1 | $74K | Buy |
40,000
+15,000
| +60% | +$27.8K | ﹤0.01% | 2455 |
|
|
2013
Q4 | $52K | Buy |
+25,000
| New | +$52K | ﹤0.01% | 2455 |
|